These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 16118215)
1. Molecular determinants for the complex formation between the retinoblastoma protein and LXCXE sequences. Singh M; Krajewski M; Mikolajka A; Holak TA J Biol Chem; 2005 Nov; 280(45):37868-76. PubMed ID: 16118215 [TBL] [Abstract][Full Text] [Related]
2. Mutagenesis of the pRB pocket reveals that cell cycle arrest functions are separable from binding to viral oncoproteins. Dick FA; Sailhamer E; Dyson NJ Mol Cell Biol; 2000 May; 20(10):3715-27. PubMed ID: 10779361 [TBL] [Abstract][Full Text] [Related]
3. The canine papillomavirus and gamma HPV E7 proteins use an alternative domain to bind and destabilize the retinoblastoma protein. Wang J; Zhou D; Prabhu A; Schlegel R; Yuan H PLoS Pathog; 2010 Sep; 6(9):e1001089. PubMed ID: 20824099 [TBL] [Abstract][Full Text] [Related]
4. Viral oncoproteins E1A and E7 and cellular LxCxE proteins repress SUMO modification of the retinoblastoma tumor suppressor. Ledl A; Schmidt D; Müller S Oncogene; 2005 May; 24(23):3810-8. PubMed ID: 15806172 [TBL] [Abstract][Full Text] [Related]
5. Three regions of the pRB pocket domain affect its inactivation by human papillomavirus E7 proteins. Dick FA; Dyson NJ J Virol; 2002 Jun; 76(12):6224-34. PubMed ID: 12021356 [TBL] [Abstract][Full Text] [Related]
6. The high-risk HPV16 E7 oncoprotein mediates interaction between the transcriptional coactivator CBP and the retinoblastoma protein pRb. Jansma AL; Martinez-Yamout MA; Liao R; Sun P; Dyson HJ; Wright PE J Mol Biol; 2014 Dec; 426(24):4030-4048. PubMed ID: 25451029 [TBL] [Abstract][Full Text] [Related]
7. Protein domains governing interactions between E2F, the retinoblastoma gene product, and human papillomavirus type 16 E7 protein. Huang PS; Patrick DR; Edwards G; Goodhart PJ; Huber HE; Miles L; Garsky VM; Oliff A; Heimbrook DC Mol Cell Biol; 1993 Feb; 13(2):953-60. PubMed ID: 7678696 [TBL] [Abstract][Full Text] [Related]
8. Structure of the retinoblastoma tumour-suppressor pocket domain bound to a peptide from HPV E7. Lee JO; Russo AA; Pavletich NP Nature; 1998 Feb; 391(6670):859-65. PubMed ID: 9495340 [TBL] [Abstract][Full Text] [Related]
9. Identification of a novel retinoblastoma gene product binding site on human papillomavirus type 16 E7 protein. Patrick DR; Oliff A; Heimbrook DC J Biol Chem; 1994 Mar; 269(9):6842-50. PubMed ID: 8120046 [TBL] [Abstract][Full Text] [Related]
10. Interactions of SV40 large T antigen and other viral proteins with retinoblastoma tumour suppressor. Lee C; Cho Y Rev Med Virol; 2002; 12(2):81-92. PubMed ID: 11921304 [TBL] [Abstract][Full Text] [Related]
11. Binding to retinoblastoma pocket domain does not alter the inter-domain flexibility of the J domain of SV40 large T antigen. Williams CK; Vaithiyalingam S; Hammel M; Pipas J; Chazin WJ Arch Biochem Biophys; 2012 Feb; 518(2):111-8. PubMed ID: 22227098 [TBL] [Abstract][Full Text] [Related]
12. Binding of the LXCXE insulin motif to a hexapeptide derived from retinoblastoma protein. Radulescu RT; Bellitti MR; Ruvo M; Cassani G; Fassina G Biochem Biophys Res Commun; 1995 Jan; 206(1):97-102. PubMed ID: 7818556 [TBL] [Abstract][Full Text] [Related]
13. Determination of the binding affinity of different human papillomavirus E7 proteins for the tumour suppressor pRb by a plate-binding assay. Dong WL; Caldeira S; Sehr P; Pawlita M; Tommasino M J Virol Methods; 2001 Oct; 98(1):91-8. PubMed ID: 11543887 [TBL] [Abstract][Full Text] [Related]
14. Adenovirus E1A, simian virus 40 tumor antigen, and human papillomavirus E7 protein share the capacity to disrupt the interaction between transcription factor E2F and the retinoblastoma gene product. Chellappan S; Kraus VB; Kroger B; Munger K; Howley PM; Phelps WC; Nevins JR Proc Natl Acad Sci U S A; 1992 May; 89(10):4549-53. PubMed ID: 1316611 [TBL] [Abstract][Full Text] [Related]
15. Role of LXCXE motif-dependent interactions in the activity of the retinoblastoma protein. Chan HM; Smith L; La Thangue NB Oncogene; 2001 Sep; 20(43):6152-63. PubMed ID: 11593423 [TBL] [Abstract][Full Text] [Related]
16. Human papillomavirus type 45 E7 is a transforming protein inducing retinoblastoma protein degradation and anchorage-independent cell cycle progression. Morandell D; Rostek U; Bouvard V; Campo-Fernández B; Fiedler M; Jansen-Dürr P; Zwerschke W Virology; 2008 Sep; 379(1):20-9. PubMed ID: 18649911 [TBL] [Abstract][Full Text] [Related]
17. Oligomerization properties of the viral oncoproteins adenovirus E1A and human papillomavirus E7 and their complexes with the retinoblastoma protein. Clements A; Johnston K; Mazzarelli JM; Ricciardi RP; Marmorstein R Biochemistry; 2000 Dec; 39(51):16033-45. PubMed ID: 11123931 [TBL] [Abstract][Full Text] [Related]
18. Structural basis for recognition of the tumor suppressor protein PTPN14 by the oncoprotein E7 of human papillomavirus. Yun HY; Kim MW; Lee HS; Kim W; Shin JH; Kim H; Shin HC; Park H; Oh BH; Kim WK; Bae KH; Lee SC; Lee EW; Ku B; Kim SJ PLoS Biol; 2019 Jul; 17(7):e3000367. PubMed ID: 31323018 [TBL] [Abstract][Full Text] [Related]
19. The human papillomavirus E7 oncoprotein and the cellular transcription factor E2F bind to separate sites on the retinoblastoma tumor suppressor protein. Wu EW; Clemens KE; Heck DV; Münger K J Virol; 1993 Apr; 67(4):2402-7. PubMed ID: 8445736 [TBL] [Abstract][Full Text] [Related]
20. Short linear motif core and flanking regions modulate retinoblastoma protein binding affinity and specificity. Palopoli N; González Foutel NS; Gibson TJ; Chemes LB Protein Eng Des Sel; 2018 Mar; 31(3):69-77. PubMed ID: 29370437 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]